Tunnel vision

AWH ANNOUNCES FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS

Retrieved on: 
Tuesday, March 12, 2024
The Company, Pressure, Growth, AWH, FY, Tunnel, Ratio, Sale, THCV, Acquisition, G&A, Capital, Nature, Cannabis, Economic problem, Ozone, GAAP, Depreciation, Tunnel vision, Total, Herb, Net income, Corporation, Video game

Q4 2023: Generated $16.7 million Cash from Operations in the quarter, representing the fourth quarter in a row the Company generated Cash from Operations.

Key Points: 
  • Q4 2023: Generated $16.7 million Cash from Operations in the quarter, representing the fourth quarter in a row the Company generated Cash from Operations.
  • Q4 2023 represented the fourth quarter in a row where the Company has experienced sequential growth in gross and net wholesale revenue.
  • Net loss attributable to AWH for Q4 2023 was $19.3 million during the quarter compared to $11.2 million in the prior quarter.
  • ET to discuss its financial results for the quarter and year ended December 31, 2023.

Phylos® and People Science® Announce Results of IRB-Backed Controlled Research Study on the Energizing Effects of THCV

Retrieved on: 
Tuesday, February 27, 2024
Research, Doctor of Philosophy, MD, THCV, Exercise, Nature, IRB, Kanha, Fatigue, Ozone, Tunnel, THC, Motivation, Cannabis, Science, GSD, Tunnel vision, Hunger, Animal feed

PORTLAND, Ore., Feb. 27, 2024 /PRNewswire/ -- Cannabis genetics company Phylos®, along with People Science, a direct-to-consumer scientific research and technology company, has conducted an IRB-approved, double-blind clinical research study on the effects of rare cannabinoid tetrahydrocannabivarin (THCV). Results of the study found that Natural Natural™ THCV by Phylos significantly increased energy, activity, motivation, and well-being compared to placebo, without the fatigue and munchies associated with THC consumption.

Key Points: 
  • Results of the study found that Natural Natural ™ THCV by Phylos significantly increased energy, activity, motivation, and well-being compared to placebo, without the fatigue and munchies associated with THC consumption.
  • "This study signifies a pivotal moment for the cannabis industry in understanding the effect of THCV in combination with THC," according to Alisha Holloway, PhD, Chief Scientific Officer at Phylos.
  • "The Natural Natural THCV study allows us to leverage our exceptional plants in the advancement of targeted cannabis products, and to chart new territories in understanding the efficacy of natural cannabinoids."
  • Research participants ingested unmedicated placebo gummies, THC-only gummies, and gummies infused with extract from Get Sh!t Done™ (GSD), a THCV-dominant plant bred by Phylos.

Revolutionizing Vision Care: Global Artificial Retina Market Grows Amid Rising Prevalence of Retinal Diseases - ResearchAndMarkets.com

Retrieved on: 
Thursday, September 14, 2023
Health, Optical, Retina, Neuron, Tunnel vision, Nyctalopia, Prevalence, AMD, Paratriathlon, Quality of life, Research, Retinitis pigmentosa, RP, Patient, Forecasting, World Health Organization, Video game, Medical device

The artificial retina market is anticipated to witness a steady growth rate of 7.5% by 2031.

Key Points: 
  • The artificial retina market is anticipated to witness a steady growth rate of 7.5% by 2031.
  • With millions of people worldwide affected by retinal degenerative diseases, leading to varying degrees of vision impairment and even blindness, the need for innovative solutions is paramount.
  • Retinal degenerative diseases, such as Age-related Macular Degeneration (AMD) and Retinitis Pigmentosa (RP), impact normal visual function and quality of life.
  • Regions such as North America and Europe are expected to be major contributors to the artificial retina market.

Innovative Goggles to Help Individuals with Autism, ADD, & ADHD Have Officially Launched Their Crowdfunding Campaign and Have Seen Great Results

Retrieved on: 
Thursday, February 17, 2022
Steps, Learning, ADD, Autism, Parent, Hope, Music therapy, Velcro, Interview, Child, Hair, ADHD, Language, Bandage, Eye, Toy, Tunnel vision, Tunnel, Indiegogo, Jillian

Some individuals have debilitating and severe "stimming" behaviors which cause major distractions in the home, classroom, or therapy settings.

Key Points: 
  • Some individuals have debilitating and severe "stimming" behaviors which cause major distractions in the home, classroom, or therapy settings.
  • "My desire is to help parents connect with their children in a deeper way, while providing hope for their future.
  • We are finally at a place to launch our crowdfunding as the last step to get Tunnel Vision Goggles world wide.
  • Tunnel Vision is the world's first non-pharmaceutical, in-home solution to reduce stimming for those with ADD, ADHD, and autism.

Funding Allows Safe Toddles To Study Benefits Of Safe Mobility Device For Blind Toddlers

Retrieved on: 
Thursday, October 7, 2021
Language, Frasier, Blind, Walking, Visual impairment, Population, Invention, Cane, Northern Illinois University, City University, University of Illinois Urbana-Champaign, Environment, Tunnel vision, Research, Learning, Safety, City University of New York, Severe cognitive impairment, Toy, Pharmaceutical industry

This study will provide the statistical data needed to demonstrate the effect of providing safe mobility to a large population of children who are blind and visually impaired."

Key Points: 
  • This study will provide the statistical data needed to demonstrate the effect of providing safe mobility to a large population of children who are blind and visually impaired."
  • Safe Toddles is a nonprofit that provides free pediatric belt canes to families of children who are blind and unable to afford one.
  • Safe Toddles (nonprofit 501c3) provides the one and only pediatric belt canes (wearable white canes) for toddlers and preschoolers who are blind and mobility visually impaired.
  • The pediatric belt cane is an innovative safe mobility solution for blind toddlers.